Tackling the Kokoda Trail for melanoma
6 April 2018
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark “Bod” Boddison.
Fraser’s trek fell in the middle of Melanoma Institute Australia’s major fundraising and awareness campaign Melanoma March which spans across 22 locations around the country, supporting, remembering and fundraising for past and present melanoma patients.
Out of sight, does not mean out of mind for Fraser and Bod. Friends for nearly 40 years, the pair remained very close after Fraser relocated to Australia from Scotland 19 years ago. “We kept in regular contact despite being on the other side of the world. He visited me in Oz on a number of occasions and I took my family to Scotland and we spent our 40th Birthday’s together”.
Bod was diagnosed with melanoma 11 years ago but was given the all clear. Six years later, due to the viciousness of melanoma, Bod had tumours in his brain, abdomen and other parts of his body. But Bod did not lose his sense of humour or positive attitude. Fraser flew to Scotland to spend some time with his lifelong friend. “Those two weeks were priceless for us”, Fraser said.
Devastatingly, Bod lost his battle on March 11th last year. Fraser took on Kokoda just over one year since Bod passed away. Fraser is hoping to fundraise and raise awareness about melanoma. Even though Scotland doesn’t cop the brunt of extreme UV rays like Australia, melanoma doesn’t discriminate.
Bod left behind his wife Ailsa and daughter Zoe who I keep in regular contact with and they are coping as well as can be expected. I also speak regularly to Bod's parents whom I have known since I was a little schoolboy & I find it very difficult speaking to them as I can hear just how terribly sad they are without Mark.
With three young children who spend a lot of time playing outside, Fraser is patently aware of the dangers of too much sun. “I was shocked to read the statistics regarding young Aussies and melanoma so that fortified my decision to raise funds”, Fraser said.
Fraser braved harsh terrain and difficult trekking conditions including extreme humidity and wet conditions. Fraser took on an incredible challenge for Melanoma Institute Australia and you can help him take it one step further by donating to his cause here.
SAVE THE DATE - Sydney Melanoma Information Forum
SAVE THE DATE:
Team Melanoma smashes City2Surf
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Ready to run over melanoma at City2Surf 2019
Lauren O'Brien tells us why she's running for a cause close to her heart
Community Fundraising July Wrap-Up
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
Breast cancer drug may hold key to tackling most deadly type of melanoma
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
MIA takes centre stage at leading cancer conference
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
International Clinical Trials Day 2019
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
Emma Betts' legacy will live on
“I’m the age Emma was when she passed away. It almost feels
Support PBS listing for three adjuvant treatments of resected Stage III melanoma
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
Support PBS listing for pembrolizumab
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
How are the Premier's Awards helping cancer researchers?
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Making a difference to many
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Melanoma breakthrough paves way for personalised treatment for all cancer patients
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March announces 2019 Principal Partner
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA experts collaborate on groundbreaking research
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Possible PBS listing for dabrafenib and trametinib
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.